The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
The Orphan Nuclear Receptor Constitutive Active/Androstane Receptor Is Essential for Liver Tumor Promotion by Phenobarbital in Mice
Abstract
Hepatocellular carcinoma (HCC) is known to progress through a step often called tumor promotion. Phenobarbital (PB) is the prototype of nongenotoxic cacinogens that promote HCC in rodents. The molecular target of PB to elicit the promotion has been the subject of intense investigations over the last 30 years since it was discovered. The nuclear receptor constitutive active/androstane receptor (CAR) is activated by PB as well as by various other xenobiotics such as therapeutic drugs and environmental pollutants. CAR activation results in the transcriptional induction of numerous hepatic genes including those that encode xenobiotic-metabolizing enzymes such as a set of cytochrome P450s. In addition to PB, many CAR activators are nongenotoxic carcinogens, but the role of CAR in liver tumor promotion remains unexplored. Using Car−/− mice, we have here examined tumor promotion by chronic treatment with PB in drinking water after tumor initiation with a single dose of the genotoxic carcinogen diethylnitrosamine. None of the Car−/− mice developed either eosinophilic foci or advanced liver tumors, whereas all Car+/+ mice developed HCC and/or adenoma by 39 weeks. The results indicate that CAR is the molecular target of promotion by PB and that activation of this receptor is an essential requirement for liver tumor development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CAR activation is the basis for phenobarbital promoted non-genotoxic or mutagen-induced hepatocarcinogenesis in mice (Huang et al., 2005; Yamamoto et al., 2004)”
From Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis (2016) · cites this paper as Yamamoto et al., 2004
In the citing paper
“which is well known as a potent tumor promoter that drives non-genotoxic hepatocarcinogenesis (Guo et al., 2003; Huang et al., 2005; Yamamoto et al., 2004; Zhang et al., 2004).”
From Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis (2016) · cites this paper as Yamamoto et al., 2004
In the citing paper
“which promotes hepatocarcinogenesis independent of exogenous mutagens (Huang et al., 2005; Yamamoto et al., 2004).”
From Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis (2016) · cites this paper as Yamamoto et al., 2004
Citations
Cites
Llovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
Honkakoski, P., Zelko, I., Sueyoshi, T., & Negishi, M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5652 · Cited by 700
Self-citationThe Repressed Nuclear Receptor CAR Responds to Phenobarbital in Activating the Human CYP2B6 Gene
Sueyoshi, T., Kawamoto, T., Zelko, I., Honkakoski, P., & Negishi, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6043 · Cited by 668
Self-citationThe nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism
Wei, P., Zhang, J., Egan-Hafley, M., Liang, S., & Moore, D. D. (2000) · Nature · doi:10.1038/35038112 · Cited by 654
Eferl, R., Ricci, R., Kenner, L., Zenz, R., David, J.-P., Rath, M., & Wagner, E. F. (2003) · Cell · doi:10.1016/s0092-8674(03)00042-4 · Cited by 474 · cited 1×
“It was shown that in mice lacking the c-Jun gene, early development of liver tumors by PB was reduced (9).”
BackgroundUeda, A., Hamadeh, H. K., Webb, H. K., Yamamoto, Y., Sueyoshi, T., Afshari, C. A., Lehmann, J. M., & Negishi, M. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.1 · Cited by 466 · cited 4×
“To begin our tumor study, the C57BL/6X129 background of the original Car / mice (16) was first changed to C3H/He by repeated backcrosses.”
BackgroundMethodInfluentialSelf-citationALTERED HEPATIC FOCI: Their Role in Murine Hepatocarcinogenesis
Pitot, H. C. (1990) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.30.040190.002341 · Cited by 190 · cited 1×
“Environmental factors, such as viral hepatitis and chemical exposure, are causally implicated in HCC occurrence and development of HCC is a multistage process, involving initiation, promotion and progression (2).”
BackgroundAydinlik, H., Nguyen, T. D., Moennikes, O., Buchmann, A., & Schwarz, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204982 · Cited by 164 · cited 1×
“The mutation of the -catenin gene, which occurs frequently in human HCC, has been observed frequently in the PB-promoted eosinophilic foci (7, 8).”
BackgroundCalvisi, D. F., Factor, V. M., Loi, R., & Thorgeirsson, S. S. (2001) · PubMed · Cited by 112
Diwan, B. A., Rice, J. M., Ohshima, M., & Ward, J. M. (1986) · Carcinogenesis · doi:10.1093/carcin/7.2.215 · Cited by 97 · cited 2×
“Tumor initiation and promotion were carried out according to a standard protocol (17).”
Background
Research works printed but not linked: 1
- Harada T, Enomoto A, Boorman GA, Maronpot RR Liver and gallbladder Maronpot RR eds. . Pathology of the mouse 1999p. 119-83. Cache River Press Vienna
Cited by
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
Diehl, A. M., & Day, C. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1503519 · Cited by 1,283
Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis
Kettner, N. M., Voicu, H., Finegold, M. J., Coarfa, C., Sreekumar, A., Putluri, N., Katchy, C. A., Lee, C., Moore, D. D., & Fu, L. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.007 · Cited by 508
“, 2004), which promotes hepatocarcinogenesis independent of exogenous mutagens (Huang et al., 2005; Yamamoto et al., 2004).”
BackgroundInfluentialOmiecinski, C. J., Vanden Heuvel, J. P., Perdew, G. H., & Peters, J. M. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq338 · Cited by 369
“…versus CAR / mice have demonstrated clearly the requirement for CAR expression in the development of mouse HCC, following promotion with either the indirect CAR activator, PB, or the direct mouse CAR activator, TCPOBOP, a similarly nongenotoxic agent (Huang et al., 2005; Yamamoto et al., 2004).”
BackgroundGeier, A., Wagner, M., Dietrich, C. G., & Trauner, M. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.04.014 · Cited by 314
Huang, W., Zhang, J., Washington, M., Liu, J., Parant, J. M., Lozano, G., & Moore, D. D. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0520 · Cited by 284
Metadata
- Authors
- Yamamoto, Y., Moore, R., Goldsworthy, T. L., Negishi, M., & Maronpot, R. R.
- Affiliations
- National Institutes of Health (US)
- 1Reproductive and Developmental Toxicology and Laboratories of
- Integrated Laboratory Systems, Inc. (US)
- Venue
- Cancer Research
- Published
- 2004-10-15
- Volume
- 64
- Issue
- 20
- Pages
- 7197-7200
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2003896111
- Cited by
- 350
- References
- 18
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 5 · 2023: 3 · 2022: 13 · 2021: 9 · 2020: 11 · 2019: 6 · 2018: 20 · 2017: 26 · 2016: 20 · 2015: 23 · 2014: 25 · 2013: 27 · 2012: 18
- FWCI
- 10.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- orphan nuclear receptor, phenobarbital, liver tumor promotion, hepatocellular carcinoma, diethylnitrosamine, non-genotoxic carcinogens, cytochrome P450 induction, xenobiotic metabolism, hepatocellular adenoma
- MeSH terms
- Constitutive Androstane Receptor, Animals, Genotype, Liver Neoplasms, Experimental, Mice, Inbred C3H, Mice, Inbred C57BL, Phenobarbital, Transcription Factors, Receptors, Cytoplasmic and Nuclear, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Orphan Nuclear Receptor Constitutive Active/Androstane Receptor Is Essential for Liver Tumor Promotion by Phenobarbital in Mice. https://app.cochat.ai/papers/10.1158/0008-5472.can-04-1459
- The paper
- Yamamoto, Y., Moore, R., Goldsworthy, T. L., Negishi, M., & Maronpot, R. R. (2004). The Orphan Nuclear Receptor Constitutive Active/Androstane Receptor Is Essential for Liver Tumor Promotion by Phenobarbital in Mice. Cancer Research. https://doi.org/10.1158/0008-5472.can-04-1459
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.